Table 4 Comparison of incremental values between FGF21/adiponectin ratio and the use of FGF21 or adiponectin alone (n = 4797)

Model 1

0.756–0.826

Ref.

Ref.

Ref.

Ref.

Ref.

 + FGF21/adiponectin ratio^a

0.766–0.833

0.731

27.1

< 0.001

0.7

0.020

Ref.

Ref.

Ref.

Ref.

Ref.

 + FGF21^a

0.765–0.832

0.772

17.4

0.021

0.4

0.101

0.955

− 23.5

0.002

− 0.3

0.014

 + Adiponectin^a

0.758–0.828

0.939

23.9

0.001

0.3

0.015

0.789

− 18.3

0.016

− 0.3

0.161

Model 2

0.708–0.780

Ref.

Ref.

Ref.

Ref.

Ref.

 + FGF21/adiponectin ratio^a

0.720–0.791

0.643

32.7

< 0.001

0.6

0.003

Ref.

Ref.

Ref.

Ref.

Ref.

 + FGF21^a

0.720–0.790

0.670

30.6

< 0.001

0.5

0.008

0.967

− 11.9

0.114

− 0.1

0.262

 + Adiponectin^a

0.710–0.782

0.924

14.6

0.052

0.1

0.074

0.714

− 31.3

< 0.001

− 0.5

0.007

Model 3

0.782–0.853

Ref.

Ref.

Ref.

Ref.

Ref.

 + FGF21/adiponectin ratio^a

0.785–0.857

0.894

26.9

< 0.001

0.6

0.050

Ref.

Ref.

Ref.

Ref.

Ref.

 + FGF21^a

0.785–0.856

0.897

19.8

0.009

0.4

0.083

0.997

− 14.7

0.051

− 0.1

0.212

 + Adiponectin^a

0.782–0.853

0.999

18.9

0.012

0.2

0.088

0.896

− 19.8

0.008

− 0.4

0.100